Hangzhou Zheda Hanyu Pharmaceutical

Zheda Hanyu Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale production of peptide-based drugs and high-end generic medications. Founded as a high-tech enterprise with ties to Zhejiang University, the company focuses on metabolic diseases, oncology, and gastrointestinal disorders. Its portfolio includes significant expertise in the synthesis of complex peptides such as Liraglutide and Octreotide. Zheda Hanyu operates advanced manufacturing facilities that comply with international GMP standards, positioning itself as a key supplier in both domestic and global markets.